Laparoscopic sleeve gastrectomy versus endoscopic sleeve gastroplasty: a systematic review and meta-analysis.

Background and study aims  Laparoscopic sleeve gastrectomy (LSG) is the current standard for bariatric surgery, but it is affected by several postoperative complications. Endoscopic sleeve gastroplasty (ESG) was created as a less invasive alternative to LSG. However, its efficacy and safety compared with LSG is unclear. Materials and methods  Relevant publications were identified in MEDLINE/Cochrane/EMBASE/OVID/ PROSPERO and NIH up to January 2020. Studies were selected that included obese patients with a baseline body mass index (BMI) between 30 and 40 kg/m² with a minimum of 12 months of follow-up and with reported incidence of complications. The mean difference in percentage of excess weight loss (%EWL) at 12 months between LSG and ESG represented the primary endpoint. We also assessed the difference in pooled rate of adverse events. The quality of the studies and heterogeneity among them was analyzed. Results  Sixteen studies were selected for a total of 2188 patients (LSG: 1429; ESG: 759) with a mean BMI 34.34 and 34.72 kg/m² for LSG and ESG, respectively. Mean %EWL was 80.32 % (± 12.20; 95 % CI; P  = 0.001; I² = 98.88) and 62.20 % (± 4.38; 95 % CI; P  = 0.005; I² = 65.52) for the LSG and ESG groups, respectively, corresponding to an absolute difference of 18.12 % (± 0.89; 95 % CI, P  = 0.0001). The difference in terms of mean rate of adverse events was 0.19 % (± 0.37; 95 %CI; χ 2  = 1.602; P  = 0.2056). Conclusions  Our analysis showed a moderate superiority of LSG versus ESG. No difference in terms of safety was shown between the two groups. ESG is a less-invasive, repeatable and reversable and acceptable option for mild-moderate obese patients.

[1]  M. Bhandari,et al.  Endoscopic sleeve gastroplasty is an effective and safe minimally invasive approach for treatment of obesity: First Indian experience , 2020, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

[2]  Taha Anbara,et al.  The advantages and disadvantages of sleeve gastrectomy; clinical laboratory to bedside review☆ , 2020, Heliyon.

[3]  A. Kalloo,et al.  Endoscopic sleeve gastroplasty versus high-intensity diet and lifestyle therapy: a case-matched study. , 2020, Gastrointestinal endoscopy.

[4]  G. Costamagna,et al.  Redo endoscopic sleeve gastroplasty: technical aspects and short-term outcomes , 2020, Endoscopy.

[5]  C. Thompson,et al.  Endoscopic sleeve gastroplasty in the management of overweight and obesity: an international multicenter study. , 2019, Gastrointestinal endoscopy.

[6]  B. A. Abu Dayyeh,et al.  Endoscopic sleeve gastroplasty for obesity: defining the risk and reward after more than 1600 procedures. , 2019, Gastrointestinal endoscopy.

[7]  A. Alqahtani,et al.  Short-term outcomes of endoscopic sleeve gastroplasty in 1000 consecutive patients. , 2019, Gastrointestinal endoscopy.

[8]  T. James,et al.  The descending gastric fundus in endoscopic sleeve gastroplasty: implications for procedural technique and adverse events , 2019, VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy.

[9]  Michael Schweitzer,et al.  Endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy: a case-matched study. , 2019, Gastrointestinal endoscopy.

[10]  A. Hegde,et al.  Seven-Year Outcomes of Laproscopic Sleeve Gastectomy in Indian Patients with Different Classes of Obesity , 2018, Obesity Surgery.

[11]  M. Schindl,et al.  Experiences with the standardized classification of surgical complications (Clavien-Dindo) in general surgery patients , 2018, European Surgery.

[12]  M. Muñoz-Navas,et al.  Spanish Consensus Document on Bariatric Endoscopy. Part 1. General considerations. , 2018, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[13]  J. Himpens,et al.  Modified endoscopic gastroplasty for the treatment of obesity , 2018, Surgical Endoscopy.

[14]  A. Kalloo,et al.  Endoscopic Sleeve Gastroplasty (ESG) Is a Reproducible and Effective Endoscopic Bariatric Therapy Suitable for Widespread Clinical Adoption: a Large, International Multicenter Study , 2018, Obesity Surgery.

[15]  C. Beglinger,et al.  Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity: The SM-BOSS Randomized Clinical Trial , 2018, JAMA.

[16]  E. Luna,et al.  Sleeve Gastrectomy Outcomes in Patients with BMI Between 30 and 35–3 Years of Follow-Up , 2017, Obesity Surgery.

[17]  L. Aronne,et al.  A single-operator learning curve analysis for the endoscopic sleeve gastroplasty. , 2017, Gastrointestinal endoscopy.

[18]  S. Kim,et al.  Short-Term Outcomes of Laparoscopic Greater Curvature Plication and Laparoscopic Sleeve Gastrectomy in Patients with a Body Mass Index of 30 to 35 kg/m2 , 2017, Yonsei medical journal.

[19]  P. Hans,et al.  Long-term outcome of laparoscopic sleeve gastrectomy from a single center in mainland China. , 2017, Asian journal of surgery.

[20]  L. Aronne,et al.  Endoscopic Sleeve Gastroplasty for Obesity: a Multicenter Study of 248 Patients with 24 Months Follow-Up , 2017, Obesity Surgery.

[21]  José Salinas,et al.  Bariatric surgery in 1119 patients with preoperative body mass index<35 (kg/m(2)): results at 1 year. , 2015, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[22]  M. Lakdawala,et al.  Single-Incision Sleeve Gastrectomy Versus Laparoscopic Sleeve Gastrectomy. A 2-Year Comparative Analysis of 600 Patients , 2015, Obesity Surgery.

[23]  Sanyuan Hu,et al.  A Randomized Clinical Trial of Laparoscopic Roux-en-Y Gastric Bypass and Sleeve Gastrectomy for the Treatment of Morbid Obesity in China: a 5-Year Outcome , 2014, Obesity Surgery.

[24]  Dijian Shen,et al.  Comparison of short-term outcomes between laparoscopic greater curvature plication and laparoscopic sleeve gastrectomy , 2013, Surgical Endoscopy.

[25]  R. Noun,et al.  Clinical Study Laparoscopic Sleeve Gastrectomy for Mildly Obese Patients (body Mass Index of 30 <35 Kg/m 2 ): Operative Outcome and Short-term Results , 2022 .

[26]  Asge Asmbs Task Force on Endoscopic Bariatric Therapy.  A pathway to endoscopic bariatric therapies. , 2011, Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery.

[27]  I. Kehagias,et al.  Randomized Clinical Trial of Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Sleeve Gastrectomy for the Management of Patients with BMI < 50 kg/m2 , 2011, Obesity surgery.

[28]  John T. E. Richardson.  The analysis of 2 × 2 contingency tables—Yet again , 2011, Statistics in medicine.

[29]  Morten Wang Fagerland,et al.  The analysis of 2 × 2 contingency tables—yet again: Author's reply , 2011 .

[30]  Michele Tarsilla.  Cochrane Handbook for Systematic Reviews of Interventions , 2010, Journal of MultiDisciplinary Evaluation.

[31]  Wei-Jei Lee,et al.  Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion. , 2010, Surgery.

[32]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.

[33]  I. Campbell.  Chi‐squared and Fisher–Irwin tests of two‐by‐two tables with small sample recommendations , 2007, Statistics in medicine.

[34]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[35]  Douglas G. Altman,et al.  Practical statistics for medical research , 1990 .

[36]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[37]  M. Camilleri,et al.  Endoscopic Sleeve Gastroplasty Alters Gastric Physiology and Induces Loss of Body Weight in Obese Individuals , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[38]  G. Cadière,et al.  [Laparoscopic sleeve gastrectomy]. , 2007, Journal de chirurgie.